RushNet (RushNet) Debt-to-Revenue : 0.00 (As of . 20)

View and export this data going back to . Start your Free Trial

What is RushNet Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

RushNet's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. RushNet's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. RushNet's annualized Revenue for the quarter that ended in . 20 was $0.00 Mil.

RushNet Debt-to-Revenue Historical Data

The historical data trend for RushNet's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RushNet Debt-to-Revenue Chart

RushNet Annual Data

Trend

Debt-to-Revenue

RushNet Quarterly Data

Debt-to-Revenue

Competitive Comparison of RushNet's Debt-to-Revenue

For the Diagnostics & Research subindustry, RushNet's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RushNet's Debt-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, RushNet's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where RushNet's Debt-to-Revenue falls into.

RushNet Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

RushNet's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(	+	)	/	N/A
	=	N/A

RushNet's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(	+	)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (. 20) Revenue data.

RushNet Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of RushNet's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

RushNet (RushNet) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RushNet Inc (OTCPK:RSHN) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

8465 Merchants Way, Suite 206, Orange Park, FL, USA, 32222

Website

https://www.rushnetinc.com

RushNet Inc through its subsidiary heliosDX, a National Clinical Reference Laboratory offers High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. The firm provides physicians individualized customer service, as well as fast and accurate reporting of results. The company invests in its infrastructure with the most efficient scientific proven instruments, and latest software for patient and physician satisfaction. It allows heliosDX to provide physicians fast and accurate reporting meeting. The firm excels in patient and client care through physician designed panels that aid in testing compliance and reporting education.